Document -
Sobi awarded Best Biotech Pipeline at World Orphan Drug Congress
Swedish Orphan Biovitrum AB (publ) (Sobi) has been awarded Best Biotech Pipeline at the World Orphan Drug Congress in Geneva. The award recognises the size and range of Sobi's orphan pipeline and also the mix across designation and authorisation phases within the portfolio.
-
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
- File format: .pdf
